202 related articles for article (PubMed ID: 6244358)
1. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
Blazar B; Patarroyo M; Klein E; Klein G
J Exp Med; 1980 Mar; 151(3):614-27. PubMed ID: 6244358
[TBL] [Abstract][Full Text] [Related]
2. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction.
Patarroyo M; Blazar B; Pearson G; Klein E; Klein G
Int J Cancer; 1980 Sep; 26(3):365-71. PubMed ID: 6270007
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
4. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
Furukawa M; Kato C; Kamide M; Umeda R
Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
[TBL] [Abstract][Full Text] [Related]
5. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
Lin JC; Raab-Traub N
J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
[TBL] [Abstract][Full Text] [Related]
6. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
7. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
Williams LR; Quinn LL; Rowe M; Zuo J
J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
Patel PC; Dorval G; Menezes J
Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.
Blazar BA; Fitzgerald J; Sutton L; Strome M
Clin Exp Immunol; 1983 Oct; 54(1):31-8. PubMed ID: 6311470
[TBL] [Abstract][Full Text] [Related]
10. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
Klein G; Vilcek J
J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
[TBL] [Abstract][Full Text] [Related]
12. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
Roubal J; Roubalová K
Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
[TBL] [Abstract][Full Text] [Related]
13. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus.
Roubalová K; Roubal J
Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760
[TBL] [Abstract][Full Text] [Related]
14. Interferon and natural killing of human lymphoma cell lines after induction of the Epstein Barr viral cycle by superinfection.
Blazar BA; Strome M; Schooley R
J Immunol; 1984 Feb; 132(2):816-20. PubMed ID: 6197476
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
16. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
Luka J; Kallin B; Klein G
Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
[No Abstract] [Full Text] [Related]
17. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes.
Steinitz M; Bakács T; Klein G
Int J Cancer; 1978 Sep; 22(3):251-7. PubMed ID: 212371
[TBL] [Abstract][Full Text] [Related]
18. Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.
Bhaduri-McIntosh S; Miller G
J Virol Methods; 2006 Oct; 137(1):103-14. PubMed ID: 16843536
[TBL] [Abstract][Full Text] [Related]
19. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
[TBL] [Abstract][Full Text] [Related]
20. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
Stoerker J; Yajima Y; Glaser R
Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
